Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 2356853, 8 pages
http://dx.doi.org/10.1155/2016/2356853
Research Article

BQ123 Stimulates Skeletal Muscle Antioxidant Defense via Nrf2 Activation in LPS-Treated Rats

1Department of Cardiovascular Physiology, Chair of Experimental and Clinical Physiology, Medical University of Lodz, 6/8 Mazowiecka Street, 92-215 Lodz, Poland
2Laboratory of Molecular Diagnostic and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostic, Medical University of Lodz, 1 Muszynskiego Street, 90-151 Lodz, Poland

Received 23 July 2015; Revised 24 September 2015; Accepted 11 October 2015

Academic Editor: Ersin Fadillioglu

Copyright © 2016 Agata Kowalczyk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Sagy, Y. Al-Qaqaa, and P. Kim, “Definitions and pathophysiology of sepsis,” Current Problems in Pediatric and Adolescent Health Care, vol. 43, no. 10, pp. 260–263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. C. F. Bolton, “Neuromuscular manifestations of critical illness,” Muscle and Nerve, vol. 32, no. 2, pp. 140–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Roth and G. E. P. De Souza, “Fever induction pathways: evidence from responses to systemic or local cytokine formation,” Brazilian Journal of Medical and Biological Research, vol. 34, no. 3, pp. 301–314, 2001. View at Google Scholar · View at Scopus
  4. C. Langhans, S. Weber-Carstens, F. Schmidt et al., “Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy,” PLoS ONE, vol. 9, no. 3, Article ID e92048, 2014. View at Publisher · View at Google Scholar
  5. M. J. Morgan and Z.-G. Liu, “Crosstalk of reactive oxygen species and NF-κB signaling,” Cell Research, vol. 21, no. 1, pp. 103–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Kuwahara, T. Horie, S. Ishikawa et al., “Oxidative stress in skeletal muscle causes severe disturbance of exercise activity without muscle atrophy,” Free Radical Biology and Medicine, vol. 48, no. 9, pp. 1252–1262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. L. Muller, W. Song, Y. C. Jang et al., “Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production,” American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, vol. 293, no. 3, pp. R1159–R1168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Meyer, H. L. Pahl, and P. A. Baeuerle, “Regulation of the transcription factors NF-κB and AP-1 by redox changes,” Chemico-Biological Interactions, vol. 91, no. 2-3, pp. 91–100, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Zhang, J. Pi, C. G. Woods, and M. E. Andersen, “A systems biology perspective on Nrf2-mediated antioxidant response,” Toxicology and Applied Pharmacology, vol. 244, no. 1, pp. 84–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Linke, V. Adams, P. C. Schulze et al., “Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle,” Circulation, vol. 111, no. 14, pp. 1763–1770, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. R. D. Bianca, N. S. Wayman, M. C. McDonald et al., “Superoxide dismutase mimetic with catalase activity, EUK-134, attenuates the multiple organ injury and dysfunction caused by endotoxin in the rat,” Medical Science Monitor, vol. 8, no. 1, pp. BR1–BR7, 2002. View at Google Scholar · View at Scopus
  12. H.-J. Appell, J. A. R. Duarte, and J. M. C. Soares, “Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy,” International Journal of Sports Medicine, vol. 18, no. 3, pp. 157–160, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. M. H. Sedeek, M. T. Llinas, H. Drummond et al., “Role of reactive oxygen species in endothelin-induced hypertension,” Hypertension, vol. 42, no. 4, pp. 806–810, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Duerrschmidt, N. Wippich, W. Goettsch, H.-J. Broemme, and H. Morawietz, “Endothelin-1 induces NAD(P)H oxidase in human endothelial cells,” Biochemical and Biophysical Research Communications, vol. 269, no. 3, pp. 713–717, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kowalczyk, P. Kleniewska, M. Kolodziejczyk, B. Skibska, and A. Goraca, “The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis,” Archivum Immunologiae et Therapiae Experimentalis, vol. 63, no. 1, pp. 41–52, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. K. E. LaBarbera, R. D. Hyldahl, K. S. O'Fallon, P. M. Clarkson, and S. Witkowski, “Pericyte NF-κB activation enhances endothelial cell proliferation and proangiogenic cytokine secretion in vitro,” Physiological Reports, vol. 3, no. 4, Article ID e12309, 2015. View at Publisher · View at Google Scholar
  17. Y. Fujii, S. Magder, P. Cernacek, P. Goldberg, Y. Guo, and S. N. Hussain, “Endothelin receptor blockade attenuates lipopolysaccharide-induced pulmonary nitric oxide production,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 3, part 1, pp. 982–989, 2000. View at Publisher · View at Google Scholar
  18. J. A. Douthwaite, D. M. Lees, and R. Corder, “A role for increased mRNA stability in the induction of endothelin-1 synthesis by lipopolysaccharide,” Biochemical Pharmacology, vol. 66, no. 4, pp. 589–594, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Piechota, M. Banach, R. Irzmanski et al., “Plasma endothelin-1 levels in septic patients,” Journal of Intensive Care Medicine, vol. 22, no. 4, pp. 232–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-F. Pittet, D. R. Morel, A. Hemsen et al., “Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis,” Annals of Surgery, vol. 213, no. 3, pp. 261–264, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Weitzberg, J. M. Lundberg, and A. Rudehill, “Elevated plasma levels of endothelin in patients with sepsis syndrome,” Circulatory Shock, vol. 33, no. 4, pp. 222–227, 1991. View at Google Scholar · View at Scopus
  22. M. M. Hynynen and R. A. Khalil, “The vascular endothelin system in hypertension—recent patents and discoveries.,” Recent Patents on Cardiovascular Drug Discovery, vol. 1, no. 1, pp. 95–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. E. Callera, R. M. Touyz, S. A. Teixeira et al., “ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension,” Hypertension, vol. 42, no. 4, pp. 811–817, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Xu, L. Lin, and W.-J. Yuan, “Antiarrhythmic effect of endothelin-a receptor antagonist on acute ischemic arrhythmia in isolated rat heart,” Acta Pharmacologica Sinica, vol. 24, no. 1, pp. 37–44, 2003. View at Google Scholar · View at Scopus
  25. S. Briyal, T. Philip, and A. Gulati, “Endothelin-a receptor antagonists prevent amyloid-β-induced increase in ET A receptor expression, oxidative stress, and cognitive impairment,” Journal of Alzheimer's Disease, vol. 23, no. 3, pp. 491–503, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Andersson, J. Fenhammar, R. Frithiof, E. Weitzberg, A. Sollevi, and H. Hjelmqvist, “Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock,” Journal of Surgical Research, vol. 149, no. 1, pp. 138–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. B. M. Toney, A. J. Fisher, M. Albrecht et al., “Selective endothelin-A receptor blockade attenuates endotoxin-induced pulmonary hypertension and pulmonary vascular dysfunction,” Pulmonary Circulation, vol. 4, no. 2, pp. 300–310, 2014. View at Publisher · View at Google Scholar
  28. R. Ozdemir, H. Parlakpinar, A. Polat, C. Colak, N. Ermis, and A. Acet, “Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury,” Toxicology, vol. 219, no. 1–3, pp. 142–149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Fujita, M. Yamafuji, Y. Nakabeppu, and M. Noda, “Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 324256, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Li, T. O. Khor, C. Xu et al., “Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis,” Biochemical Pharmacology, vol. 76, no. 11, pp. 1485–1489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Jiang, Z. Zhou, Q. Meng et al., “Ginsenoside Rb1 treatment attenuates pulmonary inflammatory cytokine release and tissue injury following intestinal ischemia reperfusion injury in mice,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 843721, 12 pages, 2015. View at Publisher · View at Google Scholar
  32. J. E. Nelson, A. Loukissa, C. Altschuller-Felberg, J. J. Monaco, J. T. Fallon, and C. Cardozo, “Up-regulation of the proteasome subunit LMP7 in tissues of endotoxemic rats,” Journal of Laboratory and Clinical Medicine, vol. 135, no. 4, pp. 324–331, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Lappas, M. Permezel, and G. E. Rice, “Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5627–5633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Lappas, “GSK3β is increased in adipose tissue and skeletal muscle from women with gestational diabetes where it regulates the inflammatory response,” PLoS ONE, vol. 9, no. 12, Article ID e115854, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Crossland, D. Constantin-Teodosiu, P. L. Greenhaff, and S. M. Gardiner, “Low-dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle,” Journal of Physiology, vol. 588, no. 8, pp. 1333–1347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-A. Kim, H.-S. Park, S.-R. Kang et al., “Suppressive effect of flavonoids from Korean Citrus aurantium L. on the expression of inflammatory mediators in L6 skeletal muscle cells,” Phytotherapy Research, vol. 26, no. 12, pp. 1904–1912, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Olesen, R. S. Biensø, S. Meinertz et al., “Impact of training status on LPS-induced acute inflammation in humans,” Journal of Applied Physiology, vol. 118, no. 7, pp. 818–829, 2015. View at Publisher · View at Google Scholar
  38. V. F. Cruzat, A. Bittencourt, S. P. Scomazzon, J. S. M. Leite, P. I. H. De Bittencourt, and J. Tirapegui, “Oral free and dipeptide forms of glutamine supplementation attenuate oxidative stress and inflammation induced by endotoxemia,” Nutrition, vol. 30, no. 5, pp. 602–611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Guo, Y. Li, Z. He et al., “Targeting endothelin receptors A and B attenuates the inflammatory response and improves locomotor function following spinal cord injury in mice,” International Journal of Molecular Medicine, vol. 34, no. 1, pp. 74–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Piechota-Polańczyk and A. Gora̧ca, “Influence of specific endothelin-1 receptor blockers on hemodynamic parameters and antioxidant status of plasma in LPS-induced endotoxemia,” Pharmacological Reports, vol. 64, no. 6, pp. 1434–1441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. N. Goyal, S. Bharti, S. Arora, M. Golechha, and D. S. Arya, “Endothelin receptor antagonist BQ-123 ameliorates myocardial ischemic-reperfusion injury in rats: a hemodynamic, biochemical, histopathological and electron microscopic evidence,” Biomedicine and Pharmacotherapy, vol. 64, no. 9, pp. 639–646, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Chen, M. Hanaoka, Y. Droma, P. Chen, N. F. Voelkel, and K. Kubo, “Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats,” European Respiratory Journal, vol. 35, no. 4, pp. 904–912, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. R. L. Ford, I. M. Mains, E. J. Hilton et al., “Endothelin-A receptor inhibition after cardiopulmonary bypass: cytokines and receptor activation,” Annals of Thoracic Surgery, vol. 86, no. 5, pp. 1576–1583, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Browatzki, J. Schmidt, W. Kübler, and R. Kranzhöfer, “Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells,” Basic Research in Cardiology, vol. 95, no. 2, pp. 98–105, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. C. J. Miller, S. S. Gounder, S. Kannan et al., “Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1822, no. 6, pp. 1038–1050, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. R. M. Wu, Y. Y. Sun, T. T. Zhou et al., “Arctigenin enhances swimming endurance of sedentary rats partially by regulation of antioxidant pathways,” Acta Pharmacologica Sinica, vol. 35, no. 10, pp. 1274–1284, 2014. View at Publisher · View at Google Scholar
  47. W. Durante, “Targeting heme oxygenase-1 in vascular disease,” Current Drug Targets, vol. 11, no. 12, pp. 1504–1516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. E. J. Park, H. J. Jang, K. Tsoyi et al., “The Heme oxygenase-1 inducer THI-56 negatively regulates iNOS expression and HMGB1 release in LPS-activated RAW 264.7 cells and CLP induced septic mice,” PLoS ONE, vol. 8, no. 10, Article ID e76293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. P. K. Datta, S. B. Koukouritaki, K. A. Hopp, and E. A. Lianos, “Heme oxygenasc-1 induction attenuates inducible nitric: oxide synthase expression and proteinuria in glomerulonephritis,” Journal of the American Society of Nephrology, vol. 10, no. 12, pp. 2540–2550, 1999. View at Google Scholar · View at Scopus
  50. T. A. Tran, A. D. Nguyen, J. Chang, M. S. Goldberg, J.-K. Lee, and M. G. Tansey, “Lipopolysaccharide and tumor necrosis factor regulate parkin expression via Nuclear factor-kappa B,” PLoS ONE, vol. 6, no. 8, Article ID e23660, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. Y.-L. Wang, K.-K. Lam, P.-Y. Cheng, and Y.-M. Lee, “Celastrol prevents circulatory failure via induction of heme oxygenase-1 and heat shock protein 70 in endotoxemic rats,” Journal of Ethnopharmacology, vol. 162, pp. 168–175, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Seo, J. H. Yang, S. C. Kim, S. K. Ku, S. H. Ki, and S. M. Shin, “The antioxidant effects of isorhamnetin contribute to inhibit COX-2 expression in response to inflammation: a potential role of HO-1,” Inflammation, vol. 37, no. 3, pp. 712–722, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Barreiro, A. S. Comtois, S. Mohammed, L. C. Lands, and S. N. A. Hussain, “Role of heme oxygenases in sepsis-induced diaphragmatic contractile dysfunction and oxidative stress,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 283, no. 2, pp. L476–L484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Taillé, R. Foresti, S. Lanone et al., “Protective role of heme oxygenases against endotoxin-induced diaphragmatic dysfunction in rats,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, pp. 753–761, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Qin, K. J. Reszka, T. Fukai, and N. L. Weintraub, “Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD,” Translational Research, vol. 151, no. 2, pp. 68–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Zhang, W. Cui, G. Li et al., “Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways,” Journal of Agricultural and Food Chemistry, vol. 60, no. 33, pp. 8171–8182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Xu, H. Li, X. Hou et al., “Punicalagin induces Nrf2/HO-1 expression via upregulation of PI3K/AKT pathway and inhibits LPS-induced oxidative stress in RAW264.7 macrophages,” Mediators of Inflammation, vol. 2015, Article ID 380218, 11 pages, 2015. View at Publisher · View at Google Scholar
  58. G. A.Visner, S. E. Chesrown, J. Monnier, U. S. Ryan, and H. S. Nick, “Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 188, no. 1, pp. 453–462, 1992. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Z. Liu, H. L. Yang, C. P. Chan, W. L. Pan, and S. K. Wu, “Induction of superoxide dismutase isozymes by tumor necrosis factor-alpha and lipopolysaccharide in cultured normal and hyperplastic gingival fibroblasts,” Journal of the Formosan Medical Association, vol. 95, no. 3, pp. 236–240, 1996. View at Google Scholar
  60. C.-C. Yang, M.-C. Ma, C.-T. Chien, M.-S. Wu, W.-K. Sun, and C.-F. Chen, “Hypoxic preconditioning attenuates lipopolysaccharide-induced oxidative stress in rat kidneys,” Journal of Physiology, vol. 582, no. 1, pp. 407–419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. I. Iitsuka, A. Motoyoshi-Yamashiro, M. Moriyama et al., “Extracellular superoxide dismutase in cultured astrocytes: decrease in cell-surface activity and increase in medium activity by lipopolysaccharide-stimulation,” Neurochemical Research, vol. 37, no. 10, pp. 2108–2116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Herzog, M. J. D. Clift, F. Piccapietra et al., “Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface,” Particle and Fibre Toxicology, vol. 10, article 11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Herzog, K. Loza, S. Balog et al., “Mimicking exposures to acute and lifetime concentrations of inhaled silver nanoparticles by two different in vitro approaches,” Beilstein Journal of Nanotechnology, vol. 5, pp. 1357–1370, 2014. View at Publisher · View at Google Scholar
  64. Y. Pang, Z. Cai, and P. G. Rhodes, “Analysis of genes differentially expressed in astrocytes stimulated with lipopolysaccharide using cDNA arrays,” Brain Research, vol. 914, no. 1-2, pp. 15–22, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Marikovsky, V. Ziv, N. Nevo, C. Harris-Cerruti, and O. Mahler, “Cu/Zn superoxide dismutase plays important role in immune response,” The Journal of Immunology, vol. 170, no. 6, pp. 2993–3001, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. Y.-C. Tsai, C.-C. Huang, L.-M. Chu, and Y.-C. Liu, “Differential influence of propofol on different cell types in terms of the expression of various oxidative stress-related enzymes in an experimental endotoxemia model,” Acta Anaesthesiologica Taiwanica, vol. 50, no. 4, pp. 159–166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. A.-J. Ren, X. Yuan, L. Lin, Y.-X. Pan, Y.-W. Qing, and W.-J. Yuan, “Effects of endothelin-11-31 on cell viabililty and [Ca2+]I in cultured neonatal rat cardiomyocytes,” Physiological Research, vol. 57, no. 3, pp. 373–378, 2008. View at Google Scholar · View at Scopus
  68. M. H. Emre, H. Erdogan, and E. Fadillioglu, “Effect of BQ-123 and nitric oxide inhibition on liver in rats after renal ischemia-reperfusion injury,” General Physiology and Biophysics, vol. 25, no. 2, pp. 195–206, 2006. View at Google Scholar · View at Scopus
  69. Y.-C. Lin, Y.-S. Lai, and T.-C. Chou, “The protective effect of alpha-lipoic acid in lipopolysaccharide-induced acute lung injury is mediated by heme oxygenase-1,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 590363, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. E. Hao, F. Lang, Y. Chen et al., “Resveratrol alleviates endotoxin-induced myocardial toxicity via the Nrf2 transcription factor,” PLoS ONE, vol. 8, no. 7, Article ID e69452, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. J.-B. Yu, J. Shi, L.-R. Gong et al., “Role of Nrf2/ARE pathway in protective effect of electroacupuncture against endotoxic shock-induced acute lung injury in rabbits,” PLoS ONE, vol. 9, no. 8, Article ID e104924, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Song, G. J. Pinniger, A. J. Bakker et al., “Lipopolysaccharide-induced weakness in the preterm diaphragm is associated with mitochondrial electron transport chain dysfunction and oxidative stress,” PLoS ONE, vol. 8, no. 9, Article ID e73457, 2013. View at Publisher · View at Google Scholar · View at Scopus